Organogenesis Holdings (ORGO) FCF Margin (2017 - 2026)

Organogenesis Holdings' FCF Margin history runs 10 years deep, the most recent figure standing at 48.3% for Q1 2026.

• In Q1 2026, FCF Margin rose 7548.0% year-over-year to 48.3%; the TTM figure through Mar 2026 stood at 3.32% (up 516.0% YoY), while the FY2025 annual figure was 4.34%, down 520.0% from the prior year.
• FCF Margin was 48.3% for Q1 2026 at Organogenesis Holdings, up from 15.41% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 48.3% in Q1 2026 to a low of 36.15% in Q2 2025.
• Historically, FCF Margin has averaged 0.07% across 5 years, with a median of 0.47% in 2022.
• The sharpest annual moves came in 2025 and 2026: FCF Margin tumbled 3724 bps in 2025, then surged 7548 bps in 2026.
• A 5-year view of FCF Margin shows it stood at 2.47% in 2022, then soared by 396 bps to 7.32% in 2023, then fell by 18 bps to 5.98% in 2024, then soared by 158 bps to 15.41% in 2025, then surged by 213 bps to 48.3% in 2026.
• The last three FCF Margin figures came in at 48.3% (Q1 2026), 15.41% (Q4 2025), and 0.56% (Q3 2025), per Business Quant data.